Clinical trial · Observational
Intravesical BCG: is the Urinary Bladder Ready to Receive it
NCT05335512CI-TRIAL-00058994not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective cohort and Prospective observational study which aims To define the healing time-frame of the resected area of the bladder after TURBT. and also to validate a grading system of healing of the bladder mucosa after TURBT. To assess the factors influencing bladder healing is also one of the secondary objectives.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Invasive Bladder Urothelial Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Patients underwent TURBT
- description
- Patients undergoing complete TURBT for evaluation of a newly diagnosed bladder lesion in TMH and found to have NMIBC (either low risk or high risk)
Primary outcomes (1)
- measure
- Time Frame after TURBT
- timeFrame
- 1 year
- description
- To define the healing time-frame of the resected area of the bladder after TURBT.
Secondary outcomes (2)
- measure
- Validate Grading System
- timeFrame
- 1 year
- description
- The score is from grade 1 to grade 4, the title for grading 'Grading of healing with time', minimum value 1 is while maximum value 4 is and higher scores means a worst outcome
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: Patients undergoing complete TURBT for evaluation of a newly diagnosed bladder lesion in TMH and found to have NMIBC (either low risk or high risk) Patient gives consent will be included (after explaining about the study). Exclusion Criteria: 1. Patient who has visible tumor on first or any subsequent cystoscopy. 2. On histopathology found to have muscle invasive bladder cancer. 3. Patient having urinary tract infection before cystoscopy
References
Publications (0)
Data not yet available
No reference posted for this study.